-
ADA President, Healthcare & Education highlights power and future potential of diabetes education and support
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES, touted the success of diabetes self-management education and support (DSMES) programs and outlined steps to build on proven strengths. Saturday’s special session also included this year’s Distinguished International Service in the Cause of Diabetes Award Lecture.
-
Dual GLP-1/GIP receptor agonist improves glycemic management and weight loss in adults living with type 1 diabetes and obesity
Klara Klein, MD, PhD, and other researchers shared results from a phase 2, double-blind, randomized study of acmopatide. Study participants also experienced improvements in blood pressure and insulin dosing.
Scientific Sessions Newsmakers
-

Symposium to introduce novel approaches to harnessing tech in diabetes management
One of the panelists, Anna Kahkoska, MD, PhD, will explain how to leverage electronic health records to automate diabetes distress screening and facilitate practitioner conversations.
-

Experts to share updates on immunotherapy trials in type 1 diabetes
Researchers, including Cate Speake, PhD, and Lauren Higdon, PhD, will share new insights into early intervention aimed at altering the progression of this type of diabetes by targeting different aspects of the immune system.
-

Symposium to examine AI’s current and near-future impact on diabetes tech
Boris Kovatchev, PhD, and other panelists will share recent developments in the application of artificial intelligence in automated insulin delivery, clinical decision-making, nutrition estimation, diabetes coaching, and more.
Presenter Profiles










